drugset / Trial / NCT00220493

Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients

NCT00220493

Phase 1 Unknown 80 enrolled Sheba Medical Center
RandomizedParallel-groupDouble-blindEct

Summary

Scientific background: Growing awareness and accumulating data regarding the cognitive impairment and its progression in multiple sclerosis (MS) patients has received an important place in neurological research in the last decade.

Timeline

Start
2003-06
Primary completion
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylphenidate Small molecule